Aytu Biopharma (AYTU) Gains from Investment Securities (2015 - 2026)
Aytu Biopharma (AYTU) reported Gains from Investment Securities of $1382.0 for Q1 2026, down 99.87% quarter-over-quarter from $1.1 million in Q2 2025.
Aytu Biopharma (AYTU) Gains from Investment Securities (2015 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 12 years of Gains from Investment Securities data on file, last reported at $1382.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $1382.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1382.0 (changed N/A YoY), and the FY2025 annual result was $211618.0, up 86.45% from the prior year.
- Gains from Investment Securities eased to $1382.0 in Q1 2026 per AYTU's latest filing, from $1.1 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.1 million in Q2 2025 and troughed at -$1.0 million in Q2 2023.
- A 5-year average of $147078.4 and a median of $63892.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities tumbled 5837.23% in 2022, then jumped 151251.35% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $75000.0 in 2022, then surged by 49.33% to $112000.0 in 2023, then soared by 298.21% to $446000.0 in 2024, then jumped by 137.44% to $1.1 million in 2025, then slumped by 99.87% to $1382.0 in 2026.
- Business Quant data shows AYTU's Gains from Investment Securities at $1382.0 in Q1 2026, $1.1 million in Q2 2025, and $446000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Aytu Biopharma | 23.76 Mn | -2.96 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,382.00 |
| Mar 31, 2026 | 1,382.00 |
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Sep 30, 2024 | 446,000.00 |
| Sep 30, 2024 | 446,000.00 |
| Jun 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 146,701.00 |
| Mar 31, 2024 | 146,701.00 |
| Sep 30, 2023 | 112,000.00 |
| Sep 30, 2023 | 112,000.00 |
| Jun 30, 2023 | -1.00 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | 52,784.00 |
| Mar 31, 2023 | 52,784.00 |
| Dec 31, 2022 | 75,000.00 |
| Dec 31, 2022 | 75,000.00 |
| Sep 30, 2022 | 74.00 |
| Sep 30, 2022 | 74.00 |